Therapeutic management of intestinal fibrosis induced by radiation therapy: from molecular profiling to new intervention strategies et vice et versa

Abstract : Chronic toxicities of locoregional and systemic oncological treatments commonly develop in long-term cancer survivors. Amongst these toxicities, post-radiotherapeutic complications alter patient's quality of life. Reduction of exposure of normal tissues can be achieved by optimization of radiotherapy. Furthermore, understanding of the fibrogenic mechanisms has provided targets to prevent, mitigate, and reverse late radiation-induced damages. This mini-review shows how (i) global molecular studies using gene profiling can provide tools to develop new intervention strategies and (ii) how successful clinical trials, conducted in particular with combined pentoxifylline-vitamin E, can take benefice of biological and molecular evidences to improve our understanding of fibrogenic mechanisms, enhance the robustness of proposed treatments, and lead ultimately to better treatments for patient's benefice.
Type de document :
Article dans une revue
Fibrogenesis & Tissue Repair, 2012, 5 (Suppl 1), pp.S13
Liste complète des métadonnées

Littérature citée [59 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00704842
Contributeur : Ed. Bmc <>
Soumis le : mercredi 6 juin 2012 - 13:07:32
Dernière modification le : jeudi 15 mars 2018 - 10:12:30
Document(s) archivé(s) le : vendredi 7 septembre 2012 - 02:30:29

Fichiers

Identifiants

  • HAL Id : inserm-00704842, version 1

Collections

Citation

Saad Hamama, Sylvie Delanian, Virginie Monceau, Marie-Catherine Vozenin. Therapeutic management of intestinal fibrosis induced by radiation therapy: from molecular profiling to new intervention strategies et vice et versa. Fibrogenesis & Tissue Repair, 2012, 5 (Suppl 1), pp.S13. 〈inserm-00704842〉

Partager

Métriques

Consultations de la notice

161

Téléchargements de fichiers

181